|
Volumn 3, Issue 1, 2002, Pages 15-21
|
Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis
a a a a a a |
Author keywords
Amyotrophic lateral sclerosis; Database; Motor neuron disease; Prognostic modelling; Riluzole
|
Indexed keywords
RILUZOLE;
ADOLESCENT;
ADULT;
AGED;
AMYOTROPHIC LATERAL SCLEROSIS;
ARTICLE;
CLINICAL TRIAL;
COHORT ANALYSIS;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DATA ANALYSIS;
DRUG EFFECT;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL SPECIALIST;
MORTALITY;
MOTOR NEURON DISEASE;
MULTIVARIATE ANALYSIS;
ONSET AGE;
PRIORITY JOURNAL;
PROGNOSIS;
RETROSPECTIVE STUDY;
SCORING SYSTEM;
STATISTICAL MODEL;
SURVIVAL;
SYMPTOMATOLOGY;
BIOLOGICAL MODEL;
MIDDLE AGED;
RISK FACTOR;
SEX DIFFERENCE;
SURVIVAL RATE;
TREATMENT OUTCOME;
UNITED KINGDOM;
VALIDATION STUDY;
AGE OF ONSET;
AMYOTROPHIC LATERAL SCLEROSIS;
COHORT STUDIES;
FEMALE;
HUMAN;
LONDON;
MALE;
MIDDLE AGE;
MODELS, BIOLOGICAL;
MODELS, STATISTICAL;
MULTIVARIATE ANALYSIS;
PROGNOSIS;
RETROSPECTIVE STUDIES;
RILUZOLE;
RISK FACTORS;
SEX FACTORS;
SUPPORT, NON-U.S. GOV'T;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
TREATMENT OUTCOME;
HUMANS;
MIDDLE AGED;
|
EID: 0035991266
PISSN: 14660822
EISSN: None
Source Type: Journal
DOI: 10.1080/146608202317576499 Document Type: Article |
Times cited : (86)
|
References (19)
|